Abstract
Intensive Induction Regimens after Deferring Initial Therapy Are Not Associated with Improved Progression-Free or Overall Survival in Patients with Mantle Cell Lymphoma (MCL)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have